Clinical trial
A Study to Evaluate the Co-Administration of MK-4618 With Antihypertensive Agents
NCT01337674 is registered in ClinicalTrials.gov with Merck Sharp & Dohme LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate the Co-Administration of MK-4618 With Antihypertensive Agents
- Lead sponsor
- Merck Sharp & Dohme LLC
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 1, 2011
- Completion date
- November 1, 2011
- Enrollment
- 26 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.